| Nonviral delivery of synthetic siRNAs in vivo S Akhtar, IF Benter The Journal of clinical investigation 117 (12), 3623-3632, 2007 | 645 | 2007 |
| Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity S Akhtar, I Benter Advanced drug delivery reviews 59 (2-3), 164-182, 2007 | 310 | 2007 |
| Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats IF Benter, CM Ferrario, M Morris, DI Diz American Journal of Physiology-Heart and Circulatory Physiology 269 (1 …, 1995 | 290 | 1995 |
| Angiotensin-(1–7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats IF Benter, MHM Yousif, GS Dhaunsi, J Kaur, MC Chappell, DI Diz American journal of nephrology 28 (1), 25-33, 2007 | 245 | 2007 |
| Angiotensin-(1–7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with l-NAME IF Benter, MHM Yousif, JT Anim, C Cojocel, DI Diz American Journal of Physiology-Heart and Circulatory Physiology 290 (2 …, 2006 | 244 | 2006 |
| 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells MM Muthalif, IF Benter, N Karzoun, S Fatima, J Harper, MR Uddin, ... Proceedings of the National Academy of Sciences 95 (21), 12701-12706, 1998 | 223 | 1998 |
| Signal transduction mechanisms involved in angiotensin-(1–7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells MM Muthalif, IF Benter, MR Uddin, JL Harper, KU Malik The Journal of pharmacology and experimental therapeutics 284 (1), 388-398, 1998 | 220 | 1998 |
| Cardiovascular actions of angiotensin (1–7) IF Benter, DI Diz, CM Ferrario Peptides 14 (4), 679-684, 1993 | 216 | 1993 |
| Angiotensin-(1–7) prevents diabetes-induced cardiovascular dysfunction IF Benter, MHM Yousif, C Cojocel, M Al-Maghrebi, DI Diz American Journal of Physiology-Heart and Circulatory Physiology 292 (1 …, 2007 | 207 | 2007 |
| Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies A Khan, M Benboubetra, PZ Sayyed, K Wooi Ng, S Fox, G Beck, IF Benter, ... Journal of drug targeting 12 (6), 393-404, 2004 | 207 | 2004 |
| Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin-and oligofectamine-induced gene expression changes in human epithelial cells Y Omidi, AJ Hollins, M Benboubetra, R Drayton, IF Benter, S Akhtar Journal of drug targeting 11 (6), 311-323, 2003 | 191 | 2003 |
| Angiotensin‐(1–7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2‐and NF‐κB‐dependent pathways AZ El‐Hashim, WM Renno, R Raghupathy, HT Abduo, S Akhtar, IF Benter British journal of pharmacology 166 (6), 1964-1976, 2012 | 189 | 2012 |
| Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats. CT Stier Jr, IF Benter, S Ahmad, HL Zuo, N Selig, S Roethel, S Levine, ... Hypertension 13 (2), 115-121, 1989 | 177 | 1989 |
| Calcium/calmodulin-dependent protein kinase IIα mediates activation of mitogen-activated protein kinase and cytosolic phospholipase A2 in norepinephrine-induced arachidonic … MM Muthalif, IF Benter, MR Uddin, KU Malik Journal of Biological Chemistry 271 (47), 30149-30157, 1996 | 172 | 1996 |
| Angiotensin II–induced hypertension: contribution of ras GTPase/mitogen-activated protein kinase and cytochrome P450 metabolites MM Muthalif, NA Karzoun, L Gaber, Z Khandekar, IF Benter, AE Saeed, ... Hypertension 36 (4), 604-609, 2000 | 150 | 2000 |
| Toxicogenomics of drug delivery systems: Exploiting delivery system-induced changes in target gene expression to enhance siRNA activity AJ Hollins, Y Omidi, IF Benter, S Akhtar Journal of drug targeting 15 (1), 83-88, 2007 | 136 | 2007 |
| A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides M Hussain, M Shchepinov, M Sohail, IF Benter, AJ Hollins, EM Southern, ... Journal of Controlled Release 99 (1), 139-155, 2004 | 116 | 2004 |
| Emerging innate biological properties of nano-drug delivery systems: A focus on PAMAM dendrimers and their clinical potential H Kheraldine, O Rachid, AM Habib, AE Al Moustafa, IF Benter, S Akhtar Advanced drug delivery reviews 178, 113908, 2021 | 115 | 2021 |
| Metabolism of vasoactive peptides by plasma and purified renal aminopeptidase M PE Ward, IF Benter, L Dick, S Wilk Biochemical pharmacology 40 (8), 1725-1732, 1990 | 114 | 1990 |
| Differential processing of substance P and neurokinin A by plasma dipeptidyl (amino) peptidase IV, aminopeptidase M and angiotensin converting enzyme L Wang, S Ahmad, IF Benter, A Chow, S Mizutani, PE Ward Peptides 12 (6), 1357-1364, 1991 | 109 | 1991 |
Saghir AkhtarQatar University College of MedicineEmail được xác minh tại qu.edu.qa
